KRN5500 in Treating Patients With Metastatic Solid Tumors
Completed · Phase 1
Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to evaluate the effectiveness of KRN5500 in treating patients with metastatic solid tumors.
Key facts
- Study ID
- NCT00002923
- Run by
- Barbara Ann Karmanos Cancer Institute
- People needed
- 27
- Starts
- 1997-05-01
- Expected to finish
- 2000-10-01
- Last updated by the study team
- 2014-04-25
Who can join
Age: 15 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.